05 | 15 | 2009 Posted By William G. Pintas
print this article

Raptiva Withdrawn from Market

On April 8, 2009 notice was sent to physicians that Genentech, Inc. voluntarily withdrew the psoriasis medication Raptiva.  This was prompted because of increased risk of progressive multifocal leukoencephalopathy (PML)

Our law firm is accepting clients who have suffered injuries from Raptiva

 

Posted In Raptiva (efalizumab)
Comments / Questions (0) | Permalink